← Insider buys
IONS

Ionis Pharmaceuticals, Inc. · Healthcare

EVP and Chief Scientific Officer C Frank Bennett sold $74K of Ionis Pharmaceuticals, Inc.

Sold$73,560
$40.57Price
1,813Shares
−3%Stake

What IONS did after the filing

Filed Feb 7, copier in the same day
The stock from Tue, Feb 7 close, $40.97
−13.9%
S&P 500, same days
−5.2%

Measured over 30 trading days, to the Mar 22 close.

Traded Mon, Feb 6. Filed Tue, Feb 7, 12:36 PM ET, during the session. Returns use the Feb 7 close and the Mar 22 close. Not investment advice.